Effects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic Complications
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors (NCT02528019) | Kurume University | 2015-08-01 |
Track Effects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic Complications automatically
Every clearance here is in the API, with alerts when new ones post.